Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Observations of medication compliance by measurement of urinary drug concentrations in a pain management population.

West R, Pesce A, West C, Crews B, Mikel C, Rosenthal M, Almazan P, Latyshev S.

J Opioid Manag. 2010 Jul-Aug;6(4):253-7.

PMID:
20862905
2.

Illicit drug use correlates with negative urine drug test results for prescribed hydrocodone, oxycodone, and morphine.

Pesce A, West C, Gonzales E, Rosenthal M, West R, Mikel C, Almazan P, Latyshev S, Horn P.

Pain Physician. 2012 Sep-Oct;15(5):E687-92. Review.

3.

Observation of improved adherence with frequent urine drug testing in patients with pain.

Yee DA, Hughes MM, Guo AY, Barakat NH, Tse SA, Ma JD, Best BM, Atayee RS.

J Opioid Manag. 2014 Mar-Apr;10(2):111-8. doi: 10.5055/jom.2014.0200.

PMID:
24715666
4.

Determination of medication cutoff values in a pain patient population.

Pesce A, West C, West R, Crews B, Mikel C, Rosenthal M, Almazon P, Latyshev S.

J Opioid Manag. 2011 Mar-Apr;7(2):117-22.

PMID:
21561035
5.

Improvement of pain physicians' practices of opioid management: population-based urinary excretion data.

Pesce A, Crews B, Latyshev S, Mikel C, Almazan P, West R, Rosenthal M, West C.

J Opioid Manag. 2011 Nov-Dec;7(6):435-41.

PMID:
22320025
6.

Interpretation of urine drug testing in pain patients.

Pesce A, West C, Egan City K, Strickland J.

Pain Med. 2012 Jul;13(7):868-85. doi: 10.1111/j.1526-4637.2012.01350.x. Epub 2012 Apr 11. Review.

7.

Does therapeutic use of tapentadol cause false-positive urine screens for methadone or opiates?

Mullins ME, Hock K, Scott MG.

Clin Toxicol (Phila). 2015 Jun;53(5):493-4. doi: 10.3109/15563650.2015.1020114. No abstract available.

PMID:
25951899
8.

Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives.

Cone EJ, Zichterman A, Heltsley R, Black DL, Cawthon B, Robert T, Moser F, Caplan YH.

Forensic Sci Int. 2010 May 20;198(1-3):58-61. doi: 10.1016/j.forsciint.2009.12.005. Epub 2009 Dec 29.

PMID:
20036472
9.

Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites.

Heltsley R, Zichterman A, Black DL, Cawthon B, Robert T, Moser F, Caplan YH, Cone EJ.

J Anal Toxicol. 2010 Jan-Feb;34(1):32-8.

11.

Urine drug testing of chronic pain patients: licit and illicit drug patterns.

Cone EJ, Caplan YH, Black DL, Robert T, Moser F.

J Anal Toxicol. 2008 Oct;32(8):530-43.

12.

An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients.

Pesce A, Rosenthal M, West R, West C, Crews B, Mikel C, Almazan P, Latyshev S.

Pain Physician. 2010 May-Jun;13(3):273-81.

13.

A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.

McCarberg BH.

Postgrad Med. 2011 Nov;123(6):124-31. doi: 10.3810/pgm.2011.11.2502. Review.

PMID:
22104461
14.

Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.

Heltsley R, DePriest A, Black DL, Robert T, Marshall L, Meadors VM, Caplan YH, Cone EJ.

J Anal Toxicol. 2011 Oct;35(8):529-40.

15.

Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine.

Cone EJ, Heit HA, Caplan YH, Gourlay D.

J Anal Toxicol. 2006 Jan-Feb;30(1):1-5.

16.

Reference intervals: a novel approach to detect drug abuse in a pain patient population.

Pesce A, West C, West R, Crews B, Mikel C, Almazan P, Latyshev S, Rosenthal M, Horn P.

J Opioid Manag. 2010 Sep-Oct;6(5):341-50.

PMID:
21046931
17.

Anomalous observations of codeine in patients on morphine.

West R, Crews B, Mikel C, Almazan P, Latyshev S, Pesce A, West C.

Ther Drug Monit. 2009 Dec;31(6):776-8. doi: 10.1097/FTD.0b013e3181c1082a.

PMID:
19935365
18.

Observations on the urine metabolic ratio of oxymorphone to oxycodone in pain patients.

Yee DA, Best BM, Atayee RS, Pesce AJ.

J Anal Toxicol. 2012 May;36(4):232-8. doi: 10.1093/jat/bks022.

PMID:
22511697
19.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
20.

6-Acetylmorphine detected in the absence of morphine in pain management patients.

Crews B, Mikel C, Latyshev S, West R, West C, Pesce A, Friel P.

Ther Drug Monit. 2009 Dec;31(6):749-52. doi: 10.1097/FTD.0b013e3181b9da04.

PMID:
19745789
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk